Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreJoerg Hasford, Rüdiger Hehlmann, Michele Baccarani et al.|Blood|2011Cited by 497
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive LeukemiaMatthew S. Zabriskie, Thomas O’Hare, H. Jean Khoury et al.|Cancer Cell|2014Cited by 366
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersFrancesca Bonifazi, Michele Baccarani, Antonio De Vivo et al.|Blood|2001Cited by 319